Giannoudis Peter V, Harwood Paul J, Tosounidis Theodoros, Kanakaris Nikolaos K
Academic Department of Trauma and Orthopaedics, Leeds Teaching Hospitals, School of Medicine, University of Leeds, Leeds, UK; NIHR Leeds Biomedical Research Unit, Chapel Allerton Hospital, Leeds, UK.
Academic Department of Trauma and Orthopaedics, Leeds Teaching Hospitals, School of Medicine, University of Leeds, Leeds, UK.
Injury. 2016 Dec;47 Suppl 6:S53-S61. doi: 10.1016/S0020-1383(16)30840-3.
This prospective study was undertaken at a regional tertiary referral centre to evaluate the results of treatment of bone defects managed with the induced membrane (IM) technique. Inclusion criteria were patients with bone defects secondary to septic non-union, chronic osteomyelitis and acute fracture with bone loss. Pathological fractures with bone loss were excluded. Data collection included patient demographics, pathology, previous surgical intervention, size of bone defect, type of graft implanted, time-to-union and complications/reinterventions. The minimum time of follow up was 12 months. Forty-three patients (32 males) met the inclusion criteria with a mean age of 47.9 years (range 18-80 years). 22 patients had an acute traumatic bone loss associated with open fracture and 21 presented with an infected non-union or underlying osteomyelitis requiring bone excision. The most common microorganisms grown were staphylcoccous aureus and coagulase negative staphylococcous. The mean length of the bone defect area was 4.2 cm (range 2-12 cm). All patients were managed with the two stage technique receiving composited grafting (Autologous bone graft (Iliac crest/RIA), graft expander as required, osteoprogenitor cells, growth factor) during the second stage. There was one failure (humeral infected non-union) in a previous background of bone radiation that necessitated reconstruction with a free fibula vascularized graft. One patient had a fall and sustained implant failure (humeral defect) 3 months after reconstruction and following re-plating progressed to union 4 months later. Two patients required re-grafting due to failure of healing in one of the defect sides. One patient presented with a discharging sinus 2 years after successful healing of a tibial defect that was treated successfully with soft tissue and bone debridement without necessitating further interventions. One patient despite union (distal 1/3 tibia) underwent a below knee amputation due to a dysfunctional ankle/foot (previous foot compartment syndrome-regional pain syndrome). Of those patients, with lower limb injuries, 4 patients had leg length discrepancies of 1 cm, 1.5 cm, 2 cm (two patients) respectively. The mean time to radiological union was 5.4 months (range 2-12 months). The average time of healing of 1 cm bone defect was 1.24 months. Patients with upper limb reconstruction recovered earlier than those with lower limb injuries. At the latest follow up all patients were able to mobilize full weight bearing without residual pain. The induced membrane technique appears to be an alternative good option for the management of large bone defects secondary to acute bone loss or infected non-unions. The incidence of re-interventions was low in this challenging cohort of patients. The technique should be considered in the surgeon's armamentarium as it is effective and is associated with a low rate of complications.
这项前瞻性研究在一家地区三级转诊中心开展,以评估采用诱导膜(IM)技术治疗骨缺损的效果。纳入标准为继发于感染性骨不连、慢性骨髓炎和伴有骨丢失的急性骨折的骨缺损患者。排除伴有骨丢失的病理性骨折患者。数据收集包括患者人口统计学信息、病理学情况、既往手术干预、骨缺损大小、植入移植物类型、骨愈合时间以及并发症/再次干预情况。最短随访时间为12个月。43例患者(32例男性)符合纳入标准,平均年龄47.9岁(范围18 - 80岁)。22例患者伴有与开放性骨折相关的急性创伤性骨丢失,21例表现为感染性骨不连或潜在骨髓炎需要进行骨切除。培养出的最常见微生物为金黄色葡萄球菌和凝固酶阴性葡萄球菌。骨缺损区域的平均长度为4.2厘米(范围2 - 12厘米)。所有患者均采用两阶段技术治疗,在第二阶段接受复合植骨(自体骨移植(髂嵴/RIA)、按需使用的植骨扩张器、骨祖细胞、生长因子)。有1例在既往骨放疗背景下出现失败(肱骨感染性骨不连),需要用游离腓骨带血管移植物进行重建。1例患者在重建后3个月摔倒,植入物失败(肱骨缺损),再次固定后4个月实现骨愈合。2例患者因一侧缺损愈合失败需要再次植骨。1例患者在胫骨缺损成功愈合2年后出现窦道,经软组织和骨清创成功治疗,无需进一步干预。1例患者尽管实现了骨愈合(胫骨远端1/3),但因踝关节/足部功能障碍(既往足部骨筋膜室综合征 - 区域疼痛综合征)接受了膝下截肢。在那些下肢受伤的患者中,4例患者的腿长差异分别为1厘米、1.5厘米、2厘米(2例患者)。放射学骨愈合的平均时间为5.4个月(范围2 - 12个月)。1厘米骨缺损的平均愈合时间为1.24个月。上肢重建的患者比下肢受伤的患者恢复得更早。在最近一次随访时,所有患者都能够完全负重活动且无残留疼痛。诱导膜技术似乎是治疗继发于急性骨丢失或感染性骨不连的大骨缺损的一个较好的替代选择。在这个具有挑战性的患者队列中,再次干预的发生率较低。该技术应被纳入外科医生的技术储备,因为它有效且并发症发生率低。